Doseloop Beta

Estropipate

medication Under review

An estrogen medication used primarily in menopausal hormone therapy to treat symptoms such as hot flashes and to prevent osteoporosis.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Scientific evidence from large-scale trials like the Women's Health Initiative primarily highlights risks rather than benefits in healthy postmenopausal women, including increased stroke, venous thromboembolism, and probable dementia with long-term use. While short-term relief from menopausal symptoms like hot flashes and vaginal atrophy is reported, consensus emphasizes that benefits do not outweigh risks for chronic disease prevention in healthy individuals, with bone loss prevention noted but not restoration to premenopausal levels.

Reported Benefits

Reported Side Effects

Research (4 studies)

RCT

Double-Blind Placebo-Controlled Study of Estropipate on Bone Mass

Not specified

Not specified

RCT

Conjugated equine estrogen influence on mammographic density in postmenopausal women in a substudy of the women's health initiative randomized trial.

JAMA • 2004 • n=10739

Women's Health Initiative Investigators

RCT

Comparison of PM2.5 Air Pollution Exposures and Health Effects Associations Using 11 Different Modeling Approaches in the Women's Health Initiative Memory Study (WHIMS).

JAMA • 2004 • n=2947

Women's Health Initiative Investigators

RCT

Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical Trial.

JAMA • 2002 • n=16508

Women's Health Initiative Investigators

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 1
Side effects noted 2